Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL668 (Protriptyline) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
GtoPdb | - | - | 8.85 | pKd | 1.41 | nM | Kd | Eur J Pharmacol (1997) 340: 249-58 [PMID:9537821] |
ChEMBL | Inhibition of human NET | B | 8.85 | pKd | 1.4 | nM | Kd | J Med Chem (2010) 53: 7869-7873 [PMID:20945906] |
ChEMBL | Displacement of radiolabeled protriptyline from human NET | B | 8.17 | pKi | 6.8 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
GtoPdb | - | - | 8.17 | pKi | 6.8 | nM | Ki | J Med Chem (2008) 51: 7094-8 [PMID:18983139] |
ChEMBL | Displacement of [3H]nisoxetine from human NE transporter | B | 8.64 | pKi | 2.3 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells after 120 mins by scintillation counting | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting | B | 8.7 | pKi | 2 | nM | Ki | J Med Chem (2012) 55: 3488-3501 [PMID:22420844] |
ChEMBL | Binding affinity to human norepinephrine transporter by radioligand displacement assay | B | 8.8 | pKi | 1.6 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Inhibition of human aorepinephrine transporter | B | 7.77 | pIC50 | 17 | nM | IC50 | Bioorg Med Chem (2010) 18: 7675-7699 [PMID:20875743] |
ChEMBL | Displacement of radiolabeled protriptyline from human NET | B | 8.04 | pIC50 | 9.1 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Inhibition of human NET | B | 8.15 | pIC50 | 7.1 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells after 120 mins by scintillation counting | B | 8.54 | pIC50 | 2.9 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells | B | 8.55 | pIC50 | 2.8 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells measured after 120 mins by scintillation counting method | B | 8.55 | pIC50 | 2.8 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Binding affinity to human nonepinephrine transporter by radioligand displacement assay | B | 8.6 | pIC50 | 2.5 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Binding affinity to human norepinephrine transporter by radioligand displacement assay | B | 8.68 | pIC50 | 2.1 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting | B | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (2012) 55: 3488-3501 [PMID:22420844] |
GtoPdb | Inhibition of [3H]nisoxetine binding to CHO cells expressing hNET. | - | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (2012) 55: 3488-501 [PMID:22420844] |
ChEMBL | Percent inhibition against Norepinephrine transporter at 1 uM nonselective | B | 8.96 | pIC50 | 1.1 | nM | IC50 | J Med Chem (2005) 48: 6887-6896 [PMID:16250647] |
Cav2.2/Voltage-gated N-type calcium channel alpha-1B subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4478] [GtoPdb: 533] [UniProtKB: Q00975] | ||||||||
ChEMBL | Inhibition of endogenous human CaV2.2 in human SH-SY5Y cells in presence of nifedipine by Calcium 4 dye based calcium influx fluorescence-imaging assay | B | 4.85 | pIC50 | 14000 | nM | IC50 | RSC Med Chem (2022) 13: 183-195 [PMID:35308021] |
SERT in Human [GtoPdb: 928] [UniProtKB: P31645] | ||||||||
GtoPdb | - | - | 7.71 | pKd | 19.6 | nM | Kd | Eur J Pharmacol (1997) 340: 249-58 [PMID:9537821] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]